|
Librela
|
10 mg
|
EU/2/20/261/004
|
Zoetis Belgium S.A., Beļģija
|
QN02BG91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Bedinvetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
10-Nov-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/261/004 |
10 mg |
1 |
Stikla flakons, 1 ml |
-
|
|
|
Simparica Trio
|
mg
|
EU/2/19/243/014
|
Zoetis Belgium S.A., Beļģija
|
QP54AB52
|
Dogs > 20-40 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner, Moxidectin, Pyrantel embonate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Corden Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
17-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/243/014 |
|
3 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
Simparica Trio
|
mg
|
EU/2/19/243/010
|
Zoetis Belgium S.A., Beļģija
|
QP54AB52
|
Dogs > 10-20 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner, Moxidectin, Pyrantel embonate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Corden Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
17-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/243/010 |
|
1 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
Dexdomitor
|
0.5 mg/ml
|
EU/2/02/033/002
|
Orion Corporation, Somija
|
QN05CM18
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Dexmedetomidine hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Orion Corporation, Somija
|
| Date of authorisation/renewal: |
02-Aug-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/02/033/002 |
0,5 mg/ml |
10 |
Stikla pudelīte, 10 ml |
-
|
|
|
Vectra 3D
|
-
|
EU/2/13/156/033
|
Ceva Sante Animale, Francija
|
QP53AC54
|
large dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Permethrin,Pyriproxyfen,Dinotefuran
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija
|
| Date of authorisation/renewal: |
27-Aug-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/156/033 |
|
24 |
Polipropilēna aplikators, 1 deva |
-
|
|
|
PRAZIVETIN
|
500 mg/g
|
EU/2/25/340/002
|
VETHELLAS S.A., Grieķija
|
QP52AA01
|
Gilthead
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
premix for medicated feeding stuff
|
| International name (active substance): |
Praziquantel
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
23-Apr-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/340/002 |
|
1 |
ZBPE maiss, 20 kg |
-
|
|
|
Coxatab
|
57 mg
|
EU/2/22/286/011
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
12-Aug-2022
|
| Marketing authorisation valid until: |
11-Aug-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/286/011 |
57 mg/tabl. |
1 |
alumīnija/PVC/PE/PVDC blisteris, 100 tablete |
-
|
|
|
MELOXIDYL
|
20 mg/ml
|
EU/2/06/070/007
|
Ceva Sante Animale., Francija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija;Vetem SpA, Itālija
|
| Date of authorisation/renewal: |
15-Jan-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/070/007 |
20 mg/ml |
1 |
Flakons, 250 ml |
-
|
|
|
Loxicom
|
20 mg/ml
|
EU/2/08/090/014
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija
|
| Date of authorisation/renewal: |
12-Mar-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/090/014 |
20 mg/ml |
6 |
Stikla flakons, 250 ml |
-
|
|
|
Nobivac Bb
|
-
|
EU/2/02/034/001
|
Intervet International Booxmer, Nīderlande
|
QI06AE02
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
powder and solvent for suspension
|
| International name (active substance): |
Live Bordetella bronchiseptica bacteria strain B-C2
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
03-Sep-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/02/034/001 |
|
5 |
Stikla flakons, 1 deva |
-
|
|
|
Daxocox
|
140 mg
|
EU/2/21/270/036
|
Ecuphar NV, Beļģija
|
QM01AH95
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Enflicoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
02-Aug-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/270/036 |
|
1 |
Blisteris, 4 tablete |
-
|
|
|
UBAC
|
deva
|
EU/2/18/227/004
|
Laboratorios Hipra S.A., Spānija
|
QI02AB
|
cattle (calf)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Streptococcus uberis
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
26-May-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/227/004 |
50 deva |
1 |
PET pudele, 100 ml |
-
|
|
|
Inflacam
|
1 mg
|
EU/2/11/134/012
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
09-Nov-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/11/134/012 |
1 mg |
1 |
Blisteris, 100 tablete |
-
|
|
|
FRONTPRO
|
136 mg
|
EU/2/19/240/014
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs >25–50 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/014 |
136 mg |
1 |
PVH/Aclar/Al blisteris, 3 tablete |
-
|
|
|
CYTOPOINT
|
40.0 mg/ml
|
EU/2/17/205/007
|
Zoetis Belgium S.A., Beļģija
|
QD11AH91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Lokivetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
26-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/205/007 |
40 mg/ml |
2 |
Stikla flakons, 1 deva |
-
|
|
|
Portela 6,4 mg
|
6.4 mg
|
EU/2/25/353/004
|
Zoetis Belgium S.A., Beļģija
|
QN02BG
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Relfovetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
27-Oct-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/353/004 |
|
1 |
Stikla flakons, 1 ml |
-
|
|
|
Loxicom
|
1 mg
|
EU/2/08/090/021
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija
|
| Date of authorisation/renewal: |
12-Mar-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/090/021 |
1 mg |
10 |
Blisteris, 10 tablete |
-
|
|
|
Bravecto
|
1400 mg
|
EU/2/13/158/030
|
Intervet International B.V., Nīderlande
|
QP53B
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet UK Ltd, Lielbritānija
|
| Date of authorisation/renewal: |
13-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/030 |
1400 mg |
1 |
Pipete, 1 deva |
-
|
|
|
Engemycin
|
100 mg/ml
|
V/I/26/0023
|
Intervet International B.V., Nīderlande
|
QJ01AA06
|
cattle; pigs; sheep; horses; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Oxytetracycline hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International GmbH, Vācija;Intervet Productions, Itālija
|
| Date of authorisation/renewal: |
08-May-2026
|
| Marketing authorisation valid until: |
07-May-2031
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 08052026LI (08-May-2026)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/26/0023-01 |
|
1 |
Flakons, 100 ml |
-
|
|
|
Metacam
|
0.5 mg/ml
|
EU/2/97/004/012
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
| Date of authorisation/renewal: |
06-Dec-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/004/012 |
0,5 mg/ml |
1 |
Polietilēna pudele, 15 ml |
-
|
|